Sumitomo Pharma Co Ltd
TSE:4506
Sumitomo Pharma Co Ltd
TSE:4506
Price:
2 031
JPY
1.93%
Market Closed
Market Cap:
¥808.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sumitomo Pharma Co Ltd
TSE:4506
|
JP |
|
With us Corp
TSE:9696
|
JP |
|
M
|
Metro Retail Stores Group Inc
XPHS:MRSGI
|
PH |
|
Manchester United PLC
NYSE:MANU
|
UK |
|
Jiangsu Azure Corp
SZSE:002245
|
CN |
|
Allison Transmission Holdings Inc
NYSE:ALSN
|
US |
|
N
|
National United Resources Holdings Ltd
HKEX:254
|
HK |
|
Jammu and Kashmir Bank Ltd
NSE:J&KBANK
|
IN |
|
M
|
Mason Capital Corp
KOSDAQ:021880
|
KR |
|
Carmila SA
PAR:CARM
|
FR |
|
E
|
Embellence Group AB (publ)
STO:EMBELL
|
SE |
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
AU |
Multiples-Based Value
The Multiples-Based Value of one
Sumitomo Pharma Co Ltd
stock under the Base Case scenario is
hidden
JPY.
Compared to the current market price of 2 031 JPY,
Sumitomo Pharma Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Sumitomo Pharma Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Sumitomo Pharma Co Ltd Competitors
Sumitomo Pharma Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
806.9B JPY | 1.8 | 7.3 | 6.8 | 8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.6 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28 | 15.6 | 22 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20.2 | 7.8 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
